Back

Improving estimation of vaccine effectiveness during outbreaks in low-resource settings: A case study of oral cholera vaccination during the 2022-2023 cholera outbreak in Malawi

Ndeketa, L.; Hungerford, D.; Pitzer, V. E.; Jere, K. C.; Jambo, K. C.; Mseka, U. L.; Kumwenda, N.; Banda, C.; Kagoli, M.; Chibwe, I.; Musicha, P.; Cunliffe, N. A.; French, N.; Dodd, P. J.

2026-03-31 infectious diseases
10.64898/2026.03.29.26349659 medRxiv
Show abstract

Background Use of oral cholera vaccine (OCV) is globally recommended as a public health response to cholera outbreaks, alongside water, sanitation and hygiene (WASH) interventions. Estimating vaccine effectiveness during emergencies in low-and middle-income countries is challenging because vaccination campaigns are often implemented over short time frames, while individual-level data are frequently incomplete due to constraints in infrastructure, resources and data systems. There is a need for pragmatic approaches that can generate timely, policy-relevant evidence using routinely collected data. Methods We analysed routine surveillance data from a large 2022-2023 cholera outbreak in Blantyre District, Malawi. The EpiEstim framework was used to generate estimates of the time-varying reproduction number (Rt) from line-listed case data. We modelled changes in Rt as a function of cumulative OCV coverage using a log-linear framework and propagated uncertainty through posterior sampling. Lagged WASH exposure variables were incorporated in the model to generate adjusted vaccine effectiveness estimates and to explore potential interaction effects. Sensitivity analyses assessed robustness to alternative lag structures. Findings The Blantyre outbreak was characterised by an initial period of low-level transmission followed by a sharp increase in cases from late November 2022, after which transmission declined steadily through April 2023. This decline coincided with the implementation of a reactive OCV campaign. The majority of the cases were among middle-aged men living in urban Blantyre. The unadjusted vaccine-associated reduction in transmission was estimated at 53.52% (95% credible interval (CrI):42.5-64.1%). After adjusting for a 7-day rolling average WASH activity, total vaccine effectiveness increased to 62.1% (95% CrI: 49.3-74.9%). Sensitivity analyses using alternative lag structures for WASH exposure produced comparable adjusted estimates. Interpretation Implementation of OCV contributed to a substantial reduction in cholera transmission during the outbreak. This study demonstrates a feasible approach for estimating vaccine-attributable impact whilst accounting for public health and social measures, such as WASH interventions. The methods described will be useful in outbreaks where classical observational designs are not possible, providing actionable evidence to policy makers for outbreak response in resource-limited settings.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
The Lancet Infectious Diseases
71 papers in training set
Top 0.2%
9.8%
2
BMC Medicine
163 papers in training set
Top 0.3%
8.2%
3
BMC Infectious Diseases
118 papers in training set
Top 0.4%
6.2%
4
The Lancet Global Health
24 papers in training set
Top 0.2%
6.1%
5
Epidemics
104 papers in training set
Top 0.3%
4.7%
6
PLOS Global Public Health
293 papers in training set
Top 2%
4.7%
7
Vaccine
189 papers in training set
Top 0.7%
4.2%
8
The Journal of Infectious Diseases
182 papers in training set
Top 1%
3.5%
9
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
3.5%
50% of probability mass above
10
Clinical Infectious Diseases
231 papers in training set
Top 2%
3.5%
11
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 2%
2.5%
12
American Journal of Epidemiology
57 papers in training set
Top 0.5%
2.4%
13
Infectious Disease Modelling
50 papers in training set
Top 0.6%
2.4%
14
International Journal of Infectious Diseases
126 papers in training set
Top 1.0%
2.4%
15
Nature Communications
4913 papers in training set
Top 46%
2.3%
16
PLOS Medicine
98 papers in training set
Top 2%
1.8%
17
Scientific Reports
3102 papers in training set
Top 57%
1.7%
18
BMJ Global Health
98 papers in training set
Top 2%
1.6%
19
PLOS ONE
4510 papers in training set
Top 55%
1.6%
20
Malaria Journal
48 papers in training set
Top 0.9%
1.6%
21
The Lancet Microbe
43 papers in training set
Top 0.7%
1.4%
22
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.3%
1.4%
23
Eurosurveillance
80 papers in training set
Top 1.0%
1.3%
24
Environmental Health Perspectives
17 papers in training set
Top 0.4%
1.3%
25
Emerging Infectious Diseases
103 papers in training set
Top 2%
1.2%
26
Wellcome Open Research
57 papers in training set
Top 1%
1.2%
27
BMC Public Health
147 papers in training set
Top 5%
1.1%
28
Canadian Medical Association Journal
15 papers in training set
Top 0.3%
0.9%
29
Epidemiology
26 papers in training set
Top 0.5%
0.8%
30
International Journal of Epidemiology
74 papers in training set
Top 3%
0.8%